Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
	Jan. 31, 2012	Jan. 31, 2011
Operating Activities
Net income (loss)	$ (1,231,202)	$ 1,676,923
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	1,411,977	1,374,052
Lower of cost or market adjustments		318,218
Change in fair value of derivative instruments	243,326	83,317
Change in operating assets and liabilities:
Restricted cash	(310,334)	(129,807)
Accounts receivable	1,030,377	(1,175,376)
Inventory	(248,160)	1,302,762
Derivative instruments	25,859	(306,580)
Prepaid expenses and other assets	(99,896)	(334,497)
Accounts payable	(961,630)	(2,338,244)
Accrued expenses	171,702	45,239
Accrued loss on forward contracts		(253,028)
Net cash provided by operating activities	32,019	262,979
Investing Activities
Capital expenditures	(775,519)	(20,561)
Net cash used in investing activities	(775,519)	(20,561)
Financing Activities
Checks written in excess of bank balance		(913,492)
Proceeds from line of credit, net		1,000,000
Payments of long-term debt	(4,621,937)	(1,189,891)
Release of restricted cash	84,949	82,753
Member contributions	707,017
Net cash used in financing activities	(3,829,971)	(1,020,630)
Net decrease in cash and equivalents	(4,573,471)	(778,212)
Cash and Equivalents - Beginning of Period	7,140,573	1,523,318
Cash and Equivalents - End of Period	2,567,102	745,106
Supplemental Cash Flow Information
Total interest paid	638,038	840,571
Cost of raising capital offset against member contributions	$ 165,045